Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 天津中新药业集团股份有限公司主营中药产品的研发、生产和销售,本部下属5家制造厂,还拥有控股公司18家,参股公司11家.公司新建的中药产业园一期工程投资 6亿元,在天津经济技术开发区建设占地24万平方米、总建筑面积6.2万平方米.该产业园是以现代中药研发、提取和制剂为核心的现代中药产业园,被列入天津市重 大高新技术产业化项目计划.现代中药产业园厂房由德国专业设计院按照FDA及GMP标准设计,配备了中药生产全过程质控检测设备,全部建成后将成为国内最大的 现代中药生产基地。
Main Business 中成药，中药材，化学原料及制剂，生物医药，营养保健品研发制造及医药商业
Legal Representative 张铭芮
Top Executives
董事长：张铭芮
董事：毛蔚雯,王磊,张铭芮,郭珉,周鸿
独立董事：刘育彬,杨木光,钟铭
Top 5 Shareholder
Shareholder name Nature Holding Date
天津市医药集团有限公司流通A股+S股42.99%30/09/2024
ABN AMRO CLEARING BANK N.V.S股9.46%30/09/2024
PHILLIP SECURITIES PTE LTDS股3.38%30/09/2024
DBS NOMINEES PTE LTDS股2.33%30/09/2024
CITIBANK NOMS SPORE PTE LTDS股1.42%30/09/2024
Company Secretary 焦艳
Solicitors 北京市君泽君律师事务所
Auditors 瑞华会计师事务所（特殊普通合伙）
Tel No 022-27020892
Fax No 022-27020892
Website www.jydrt.com.cn
Email drt600329@163.com
Company Address
Register: 天津市南开区白堤路17号
Office: 天津市南开区白堤路17号
Listing Date 06/06/2001
Shares Capital
Shares Capital: 770,158,276
Total A Share: 570,158,276
Listed A Share: 565,868,076
Non-tradable A Share: 4,290,200
Other Share: 200,000,000
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.280
DPS(RMB)* ¥ 1.280
NBV Per Share(RMB)* ¥ 8.571
Market Capitalization(RMB) 19.636B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.